News

Distributors, retail pharmacy and others pile into the specialty-pharma services

Proportion of cold chain products continues to grow in the biopharma inventory

Proportion of cold chain products continues to grow in the biopharma inventory

MTS' Credo brand now becomes a Pelican property

Annual Tompkins Global Trade Management Report surveys industry practices

Companies facing fewer funding sources, reimbursement issues

Agency is trying to quantify the effects of abuse-deterrent formulations

Structure provides a global network to standardize media strategy, buying and digital-search services

Step is one of the first toward consolidation of electronic health providers and information publishers

Lack of quantitative clinical results and FDA regulatory uncertainty leave unclear benefits for this $300-billion problem

Distinguishing between pharmaceutical manufacturing and pharmacy compounding remains a policy conflict

PwC's annual analysis sees bright spots in R&D practices, while global economic troubles will constrain healthcare spending

Peer-reviewed study correlates adverse drug events (ADEs) with form of drug administration; can pharma manufacturers help?

Implementation of the Physicians Sunshine Act may require you to begin data gathering by Feb. 25, but questions remain over the law's details, from data to dollars

Financial-services firm's index of biotech stocks rose 40.5% in 2012; predicts a better year for financings and M&A activity in 2013

New report assesses the progress in adopting both of these marketing techniques

Patent-pending technology provides an 'e-fingerprint' to go with barcode data; data can be retrieved from a cloud-based repository

Cardinal is top wholesaler in the ranking, while Mayo Foundation is the top integrated delivery network, CVS Carmark the top retail pharmacy, and Becton Dickinson the top medical products supplier

Next-gen SenseAware 2000 is deployed, along with a wider international distribution

When drugs in development today hit the marketplace in 2020, they will need evidence of economic and clinical value results to be commercially successful

Pharmaceutical marketing is now operating in a new landscape--the Economy of Attention

Abbott's spinout of AbbVie offers lessons

The 8,000th store opens in Los Angeles; landmarked bank building is a second Chicago flagship store

A new policy debate over drug regulation is emerging as the NECC scandal worsens

The looming California e-pedigree standards do not specify how to generate product codes, but random codes are easy to produce and essential for supply chain security

The Movianto acquisition presages a new era for the company

As the number of adverse events (AEs) grows year by year, regulators and industry managers are looking at automated systems to handle the burden